3 hours Second Line Capital LLC Buys New Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) MarketBeat
Second Line Capital LLC purchased a new position in Ocular Therapeutix, Inc. (NASDAQ:OCUL – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 262,810 shares of the biopharm…